» Articles » PMID: 38664615

Epidemiological Variations and Trends in Glaucoma Burden in the Belt and Road Countries

Overview
Journal BMC Ophthalmol
Publisher Biomed Central
Specialty Ophthalmology
Date 2024 Apr 25
PMID 38664615
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Analyzing the glaucoma burden in "Belt and Road" (B&R) countries based on age, gender, and risk factors from 1990 to 2019 in order to provide evidence for future prevention strategies.

Methods: We applied global burden of disease(GBD) 2019 to compare glaucoma prevalence and Years lived with disabilities (YLDs) from 1990 to 2019 in the B&R countries. Trends of disease burden between 1990 and 2019 were evaluated using the average annual percent change and the 95% uncertainty interval (UI) were reported.

Results: From 1990 to 2019, most B&R countries showed a downward trend in age-standardized prevalence and YLDs (all P < 0.05). Additionally, only the age-standardized YLDs in males of Pakistan has a 0.35% increase (95%CI:0.19,0.50,P < 0.001), and most B&R countries has a decline(all P < 0.05) in age-standardized YLDs in every 5 years age group after 45 years old except for Pakistan(45-79 years and > 85 years), Malaysia(75-84 years), Brunei Darussalam(45-49 years), Afghanistan(70-79 years). Finally, in all Central Asian countries, the age-standardized YLDs due to glaucoma caused by fasting hyperglycemia demonstrated have an increase between 1990 and 2019 (all P < 0.05), but Armenia and Mongolia have a decrease between 2010 and 2019 (all P < 0.05).

Conclusion: The prevalence of glaucoma continues to pose a significant burden across regions, ages, and genders in countries along the "B&R". It is imperative for the "B&R" nations to enhance health cooperation in order to collaboratively tackle the challenges associated with glaucoma.

References
1.
Hsu C, Chen R, Lin S . Myopia and glaucoma: sorting out the difference. Curr Opin Ophthalmol. 2015; 26(2):90-5. DOI: 10.1097/ICU.0000000000000124. View

2.
Jia P, Wang Y . Global health efforts and opportunities related to the Belt and Road Initiative. Lancet Glob Health. 2019; 7(6):e703-e705. DOI: 10.1016/S2214-109X(19)30062-2. View

3.
. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

4.
Huang Y . The Health Silk Road: How China Adapts the Belt and Road Initiative to the COVID-19 Pandemic. Am J Public Health. 2022; 112(4):567-569. PMC: 8961842. DOI: 10.2105/AJPH.2021.306647. View

5.
Morgan I, French A, Ashby R, Guo X, Ding X, He M . The epidemics of myopia: Aetiology and prevention. Prog Retin Eye Res. 2017; 62:134-149. DOI: 10.1016/j.preteyeres.2017.09.004. View